Voyager Therapeutics, Inc. Other Current Liabilities
Voyager Therapeutics, Inc. (VYGR) had Other Current Liabilities of $7.23 million as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2025-03-11
- 2024-12-31: Other Liabilities, Current $7.23M.
- 2024-09-30: Other Liabilities, Current $6.98M.
- 2024-06-30: Other Liabilities, Current $6.74M.
- 2024-03-31: Other Liabilities, Current $5.94M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2024-12-31 | $7.23M 10-K · filed 2025-03-11 | |
| 2024-09-30 | $6.98M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.74M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $5.94M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $3.20M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $3.11M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $3.01M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $2.92M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.83M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $2.75M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.53M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $5.75M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $5.57M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $5.25M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $4.87M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $4.60M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $4.20M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $3.54M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.42M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.31M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $3.19M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $3.02M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $2.84M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.19M 10-Q · filed 2020-05-06 | $2.67M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |